• About us
    • Origin, aspirations and mission statement
    • Organization
  • The stakeholders
    • The operational team
    • Members
    • Committees
  • Submit a project
    • Types of projects
    • Support from the Association
    • The opportunities
  • Our achievements
    • Current projects
    • Dialogue with the French National Authority for Health
    • The Cancer Data Platform
  • IN THE HEADLINES
    • Articles
    • Interviews
    • News
    • 1st Day of the Artificial Intelligence & Cancers Association
  • Contact
Menu
  • About us
    • Origin, aspirations and mission statement
    • Organization
  • The stakeholders
    • The operational team
    • Members
    • Committees
  • Submit a project
    • Types of projects
    • Support from the Association
    • The opportunities
  • Our achievements
    • Current projects
    • Dialogue with the French National Authority for Health
    • The Cancer Data Platform
  • IN THE HEADLINES
    • Articles
    • Interviews
    • News
    • 1st Day of the Artificial Intelligence & Cancers Association
  • Contact
  • FR

Day: September 11, 2023

The Artificial Intelligence & Cancer Association and the commitment of its Administrators: Interview with Stéphanie Combes, Director of the Health Data Hub

In this seventh interview, you will discover why the Hub, which provides medical administrative data as well as other data sources from its catalog, has decided to get involved in this Pathway project.

Filière Intelligence Artificielle & Cancers

AMGEN | ARIIS | AstraZeneca | Bristol Myers Squibb | France Biotech | Health Data Hub | Institut national du cancer | JANSSEN | MSD | Novartis | Pfizer | Pierre Fabre | Roche Diagnostics

PariSanté Campus

2-10 rue d’Oradour-sur-Glane
75015 PARIS
  • Legal Mentions
  • Data protection and privacy
  • Contact
  • Legal Mentions
  • Data protection and privacy
  • Contact

Copyright © 2023 by mlcom. Tous les droits sont réservés.

Youtube Linkedin